| | |
| 1101 | Salivary Dysfunction and Quality of Life in Sjogren's Syndrome
C. STEWART1, I. BHATTACHARYYA2, K.M. BERG2, S. CHA2, and J. KATZ2, 1University of Florida College of Dentistry, Gainesville, USA, 2University of Florida, Gainesville, USA |
| 1102 | Resting EKG Findings in Diagnosed Primary Sjögren's Syndrome
M.L. SINGH1, E. ARKEMA1, K. GANDA1, M.K. CASEY1, E. TZAVARAS1, K. JOHNSON2, and A.S. PAPAS1, 1Tufts University School of Dental Medicine, Boston, MA, USA, 2Parion Sciences, Inc, Durham, NC, USA |
| 1103 | Levels of Aldosterone Findings in Diagnosed Primary Sjögren's Syndrome Patients
E. ARKEMA1, M.L. SINGH1, K. GANDA1, K. JOHNSON2, and A.S. PAPAS1, 1Tufts University School of Dental Medicine, Boston, MA, USA, 2Parion Sciences, Inc, Durham, NC, USA |
| 1104 | Gene expression profile of Sjogren's Syndrome patients: Difference/Similarity to SLE
E.S. EMAMIAN1, J. LEON1, E.C. BAECHLER1, L.M. TOBON1, A.J. HUANG1, B. SEGAL1, N.L. RHODUS1, M. PETRI2, P.K. GREGERSEN3, T.W. BEHRENS1, and K.L. MOSER1, 1University of Minnesota, Minneapolis, USA, 2Johns Hopkins University School of Medicine, Baltimore, MD, USA, 3Feinstein Institute for Medical Research, Manhasset, NY, USA |
| 1105 | Relationship between Disease, Medicine and Stimulated Saliva and Oral Moisture
F. TAKAHASHI, M. TAKAHASHI, S. TOYA, T. KOJI, and O. MORITA, Nippon Dental University, Niigata, Japan |
| 1106 | Demographic Profile of Subjects with Medication-Induced Xerostomia at Three Locations
J. BOWMAN1, S. SHIRODARIA2, A. GALLAGHER1, J. KRAWCZUK3, and D. HAMLIN4, 1Hill Top Research, Miamiville, OH, USA, 2GlaxoSmithKline, Surrey, United Kingdom, 3Hill Top Research, West Palm Beach, FL, USA, 4Contract Dental Evaluations, Langhorne, PA, USA |
| 1107 | Objective Parameters for Assessing Subjective Oral Dryness
M. OKANE, N. KITAGAWA, Y. SATO, Y. KITAMURA, and J. MASHIMO, Showa University, Tokyo, Japan |
| 1108 | Standardization effect on reliability of salivary measurements - a methodological study
J. ALEKSEJUNIENE, M. KIM, A. CHAN, and C. CLARK, University of British Columbia, Vancouver, Canada |
| 1109 | Relationship between the viscosity and the Diffusion Rate of Saliva
K. SHIBUYA1, M. ISHIKAWA1, N. TAKEI1, and Y. KAKINOKI2, 1The Lion Foundation for Dental Health, Tokyo, Japan, 2Kyushu Dental College, Kitakyushu, Japan |
| 1113 | Salivary findings in pregnant and non-pregnant women
M. LATVA-AHO1, R. PAJUKANTA2, T. SORSA2, and E. KONONEN1, 1National Public Health Institute (KTL), Helsinki, Finland, 2University of Helsinki, Finland |
| 1114 | Saliva's flow rate, buffer capacity and pH on autistic individuals
I.H. BASSOUKOU1, W.A. DA CUNHA1, J. NICOLAU2, and M.T.B.R. SANTOS1, 1Universidade Cruzeiro do Sul, São Paulo, Brazil, 2University of Sao Paulo, Brazil |
| 1115 | Comparison of Saliva Viscosity of Edentulous and Dentulous Subjects
Y. YONEYAMA, M. MOROKUMA, T. KOYAMA, and T. HOSOI, Tsurumi University, Yokohama, Japan |
| 1116 | Effects of Sleep Bruxism Behavior on Salivary Stress Biomakers
M. MAKINO, M. TAKENAKA, C. MASAKI, and R. HOSOKAWA, Kyushu Dental College, Kitakyushu, Japan |
| 1118 | Salivary Beta-glucosidase Activity in Oro-pharyngeal Cancer and Control Patients
E.W. JONES, L.F. SHAPIRO, N.G. DUFFY, and S.G. REED, Medical University of South Carolina, Charleston, USA |
|